To hear about similar clinical trials, please enter your email below
Trial Title:
Observational Study of the Decision Making Towards Clinical Trials in Cancer Patients
NCT ID:
NCT01341210
Condition:
Lung Cancer
Liver Cancer
Conditions: Official terms:
Liver Neoplasms
Conditions: Keywords:
Patients Satisfaction
Decision Making
Informed Consent
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Cross-Sectional
Summary:
This is a cross-sectional, observational and correlational survey study.This study is aim
to survey the the knowledge, attitudes, and decision making towards clinical trials in
cancer patients in Taiwan (R.O.C.), which attempts to invite some cancer patients who
have been experienced the treatment clinical trials' informed consent process. The
research tool is a questionnaire which includes some scale: (1)Clinical trial Knowledge
scale, (2) Attitude toward randomized clinical trials scale, (3) Shared Decision
Making(SDM-Q-9),(4) Satisfaction with Decision (SWD-scale), and (5) Decision Regret
scale(DRS). The investigators expect the research outcome can provide some instructions
to improve patients' autonomy, satisfaction of the decision making and communication
process between patients and Medical professors whenever cancer patients participating in
clinical trials.
Detailed description:
This study is been conduct in National Taiwan University Hospital , Taiwan. The main
measurement tool is a self-report questionnaire, which is designed to answer some outcome
measures for the following aspect:
1. To find out the knowledge, attitudes, shared decision making level, subjective norm,
and behavior intentions towards clinical trials in cancer patients.
2. To find out the main influencing factors of behavior intentions towards
participating in clinical trials
Criteria for eligibility:
Study pop:
Adult, cancer patients who have experience in contact with clinical trials
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. Cancer patients who have been approved lung cancer or liver cancer.
2. Patients who have been experienced the Informed consent process about clinical
trial, which duration is in 6 months before they enter this study.
Exclusion Criteria:
1. Patients who have conscious disorientation that can not answer questionnaire
2. Patients only participate in some Gene clinical trials without treatment or drugs.
Gender:
All
Minimum age:
20 Years
Maximum age:
90 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
National Taiwan University Hospital
Address:
City:
Taipei
Country:
Taiwan
Status:
Recruiting
Contact:
Last name:
Wen-Yu Hu, PHD
Phone:
+886-2-23123456
Phone ext:
63160
Email:
ntuhrec@ntuh.gov.tw
Investigator:
Last name:
Wen-Yu Hu, PHD
Email:
Principal Investigator
Start date:
February 2011
Completion date:
February 2014
Lead sponsor:
Agency:
National Taiwan University Hospital
Agency class:
Other
Source:
National Taiwan University Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT01341210
